Industry News

Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Eminent Spine Publishes Clinical Evidence on World's First FDA-Cleared 3D Printed Titanium Pedicle Screw: Clinical study results released by Eminent Spine confirm zero hardware complications or bone-implant interface failures in its 3D printed titanium pedicle screw platform, establishing clinical validation for additive manufactured pedicle fixation.
• Wearable Augmented Reality Enters Intraoperative Spine Guidance:Ruthless Spine announced a strategic integration with NuEyes smart glasses, bringing real-time intraoperative angular measurements directly to the surgeon's line of sight during spinal instrumentation.
• Advanced Biomaterials & MedTech Consolidation Signals:SINTX Technologies projects Q3 revenue growth driven by silicon nitride spinal implants, while industry reports indicate continued interest from major multinationals in strategic orthopaedic acquisitions.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Ruthless Spine & NuEyes — Partner to Integrate AR Wearable Surgical Guidance for Spine Surgery

• Summary: Ruthless Spine announced a strategic partnership to integrate its digital spine navigation software with NuEyes wearable smart glasses platforms. The combined solution displays real-time intraoperative angular measurements, pedicle trajectory feedback, and anatomical alignment metrics directly within the surgeon's field of view. By eliminating the need to look away at external monitors, the hands-free AR platform aims to improve pedicle screw placement speed and accuracy while reducing operating room clutter.
• Key Details:
  • Device/System Name: Ruthless Spine AR Guidance / NuEyes Smart Glasses
  • Status: Commercial Integration / Strategic Partnership
  • Clinical Significance: Enhances surgical ergonomics and trajectory accuracy by streaming real-time biomechanical feedback directly into the operative field.
• Original Source:Orthopedics This Week Announcement

Spine & Orthobiologics

Eminent Spine — Releases Clinical Study Results for 3D Printed Titanium Pedicle Screw Platform

• Summary: Eminent Spine published early clinical study data evaluating the world's first FDA 510(k)-cleared 3D printed titanium pedicle screw system. The study tracked clinical outcomes across posterior lumbar fusion procedures, reporting zero hardware failures, revision procedures, or loosening complications. The proprietary porous titanium surface architecture demonstrated rapid osseointegration and mechanical stability under high biomechanical loading.
• Key Details:
  • Device/System Name: 3D Printed Titanium Pedicle Screw System
  • Status: Clinical Trial Results Published / FDA 510(k) Cleared
  • Clinical Significance: Validates the safety and osteoconductive advantages of additive-manufactured pedicle screws in reducing pseudarthrosis and hardware loosening.
• Original Source:Eminent Spine Clinical Study Release

SINTX Technologies — Issues Q3 Revenue Outlook ($900K–$1.1M) Driven by Silicon Nitride Interbody Implants

• Summary: SINTX Technologies issued a mid-year 2026 business update and Q3 revenue guidance of $900,000 to $1.1 million, citing expanding surgeon adoption of its silicon nitride ceramic interbody fusion cages. SINTX's biomaterial technology offers unique antibacterial properties, artifact-free imaging under MRI/CT, and high fracture toughness compared to traditional PEEK or porous titanium options.
• Key Details:
  • Device/System Name: Silicon Nitride Interbody Fusion Implants
  • Status: Commercial Expansion / Corporate Guidance
  • Clinical Significance: Combines antibacterial surface properties with radiolucency and osteoconductivity, lowering surgical site infection risks in complex fusion cases.
• Original Source:SINTX Technologies SEC Update

Corporate, M&A & Regulatory

Multinationals Evaluate Strategic Opportunities Amid $62B Market Growth

• Summary: MedTech market intelligence reports highlight ongoing M&A evaluation among major orthopaedic players, including Stryker examining expansion opportunities within the $4.4 billion orthopaedic market segment. As the global orthopaedics market approaches $62 billion, major multinationals are focusing capital allocation toward high-growth ambulatory surgery center (ASC) technologies, specialized extremities platforms, and digital surgical ecosystems.
• Key Details:
  • Device/System Name: Global Orthopaedics & ASC Technology Market
  • Status: Industry Market Intelligence
  • Clinical Significance: Signals continued investment in outpatient surgical infrastructure, smart instrumentation, and specialized subspecialty implants.
• Original Source:MD+DI Orthopaedic M&A Report

NEW FDA 510(k) & PMA CLEARANCE LISTING (PAST 24–48 HOURS)